English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Jamie Barrand | Jan 8, 2016

Children born as result of infertility treatments no more likely to experience developmental delays

+ Technology/Innovation
Jamie Barrand | Jan 8, 2016

FDA grants priority review to therapy for HCV, cirrhosis

+ Regulatory
Jamie Barrand | Jan 8, 2016

Bill to repeal Obamacare passes House, awaits presidential approval

+ Technology/Innovation
Jamie Barrand | Jan 8, 2016

International pharmaceutical study uncovers new drug combination as possible HIV therapy

+ Technology/Innovation
Jamie Barrand | Jan 8, 2016

FDA indicates Omnigraft wound dressing for treatment of diabetic foot ulcers

+ Regulatory
Jamie Barrand | Jan 8, 2016

Clinton unveils plans for autism programs in Sioux City, Iowa

+ Technology/Innovation
Jamie Barrand | Jan 8, 2016

FDA emphasizes importance of hearing aid use, plans public workshop

+ Community
Jamie Barrand | Jan 8, 2016

American Diabetes Association CEO thanks outgoing board members

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 479
  • 480
  • 481
  • 482
  • 483
  • 484
  • 485
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily